1. Home
  2. QNCX vs BRID Comparison

QNCX vs BRID Comparison

Compare QNCX & BRID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNCX
  • BRID
  • Stock Information
  • Founded
  • QNCX 2012
  • BRID 1932
  • Country
  • QNCX United States
  • BRID United States
  • Employees
  • QNCX N/A
  • BRID N/A
  • Industry
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • BRID Specialty Foods
  • Sector
  • QNCX Health Care
  • BRID Consumer Staples
  • Exchange
  • QNCX Nasdaq
  • BRID Nasdaq
  • Market Cap
  • QNCX 47.7M
  • BRID 70.3M
  • IPO Year
  • QNCX 2019
  • BRID N/A
  • Fundamental
  • Price
  • QNCX $2.00
  • BRID $7.66
  • Analyst Decision
  • QNCX Strong Buy
  • BRID
  • Analyst Count
  • QNCX 5
  • BRID 0
  • Target Price
  • QNCX $8.00
  • BRID N/A
  • AVG Volume (30 Days)
  • QNCX 374.6K
  • BRID 6.1K
  • Earning Date
  • QNCX 08-12-2025
  • BRID 08-22-2025
  • Dividend Yield
  • QNCX N/A
  • BRID N/A
  • EPS Growth
  • QNCX N/A
  • BRID N/A
  • EPS
  • QNCX N/A
  • BRID N/A
  • Revenue
  • QNCX N/A
  • BRID $224,673,000.00
  • Revenue This Year
  • QNCX N/A
  • BRID N/A
  • Revenue Next Year
  • QNCX N/A
  • BRID N/A
  • P/E Ratio
  • QNCX N/A
  • BRID N/A
  • Revenue Growth
  • QNCX N/A
  • BRID N/A
  • 52 Week Low
  • QNCX $0.51
  • BRID $7.50
  • 52 Week High
  • QNCX $2.45
  • BRID $14.69
  • Technical
  • Relative Strength Index (RSI)
  • QNCX 70.90
  • BRID 41.76
  • Support Level
  • QNCX $1.55
  • BRID $7.78
  • Resistance Level
  • QNCX $1.71
  • BRID $8.74
  • Average True Range (ATR)
  • QNCX 0.15
  • BRID 0.26
  • MACD
  • QNCX 0.02
  • BRID -0.02
  • Stochastic Oscillator
  • QNCX 89.09
  • BRID 3.23

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

About BRID Bridgford Foods Corporation

Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The business segments are; the processing and distribution of frozen products, and the processing and distribution of snack food products. Its product offerings include meat snacks, breads and rolls, biscuits, and ready-to-eat sandwiches among others. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, and mass merchandise and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. A majority of the company's revenue is derived from the snack food products segment.

Share on Social Networks: